Literature DB >> 5694289

Corticosteroids in the treatment of optic nerve involvement associated with thyroid dysfunction.

R M Day, F D Carroll.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 5694289     DOI： 10.1001/archopht.1968.03850040281009

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN： 0003-9950


× No keyword cloud information.
  9 in total

1.  Thyroid-associated orbitopathy.

Authors:  Adel H Alsuhaibani; Jeffrey A Nerad
Journal:  Semin Plast Surg       Date:  2007-02       Impact factor: 2.314

Review 2.  Immunosuppressant therapy of thyroid eye disease.

Authors:  G Kahaly; J Beyer
Journal:  Klin Wochenschr       Date:  1988-11-01

3.  Ocular manifestations of Graves' disease: therapeutic approaches.

Authors:  R M Day
Journal:  Bull N Y Acad Med       Date:  1977-04

4.  Graves' ophthalmopathy: III. Effect of transantral orbital decompression on optic neuropathy.

Authors:  E S Hallin; S E Feldon; J Luttrell
Journal:  Br J Ophthalmol       Date:  1988-09       Impact factor: 4.638

5.  Treatment of thyroid associated ophthalmopathy with periocular injections of triamcinolone.

Authors:  R Ebner; M H Devoto; D Weil; M Bordaberry; C Mir; H Martinez; L Bonelli; H Niepomniszcze
Journal:  Br J Ophthalmol       Date:  2004-11       Impact factor: 4.638

6.  Treatment of upper eyelid retraction related to thyroid-associated ophthalmopathy using subconjunctival triamcinolone injections.

Authors:  Sung Jun Lee; Tyler Hyung Taek Rim; Sun Young Jang; Chan Yun Kim; Dong Yeob Shin; Eun Jig Lee; Sang Yeul Lee; Jin Sook Yoon
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-09-12       Impact factor: 3.117

7.  Compressive Optic Neuropathy and Repeat Orbital Decompression: A Case Series.

Authors:  Courtney Y Kauh; Shivani Gupta; Raymond S Douglas; Victor M Elner; Christine C Nelson; Leslie M Niziol; Alon Kahana
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2015 Sep-Oct       Impact factor: 1.746

8.  The value of visual evoked potentials in optic neuropathy of Graves' disease.

Authors:  K Setälä; C Raitta; M Välimäki; V Katevuo; B A Lamberg
Journal:  J Endocrinol Invest       Date:  1992-12       Impact factor: 4.256

9.  Early efficacy of teprotumumab for the treatment of dysthyroid optic neuropathy: A multicenter study.

Authors:  Connie M Sears; Yao Wang; Lucy A Bailey; Roger Turbin; Prem S Subramanian; Raymond Douglas; Kimberly Cockerham; Andrea L Kossler
Journal:  Am J Ophthalmol Case Rep       Date:  2021-05-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.